Evidence map›Paper›PMID 37902840›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2024

Machine learning for risk stratification of thyroid cancer patients: a 15-year cohort study.

Shiva Borzooei, Giovanni Briganti, Mitra Golparian, Jerome R Lechien, Aidin Tarokhian

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Machine learning for predicting muscle loss after radiotherapy using clinical and toxicity data in oral cavity cancer.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Erosion of the temporal bone by vestibular schwannoma: morphometrics and predictive modeling.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Article
  12. Thy-DAMP: deep artificial neural network model for prediction of thyroid cancer mortality.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shiva BorzooeiDepartment of Endocrinology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Giovanni BrigantiChair of AI and Digital Medicine, Faculty of Medicine, University of Mons, Mons, France.
Mitra GolparianHamadan University of Medical Sciences, Pajoohesh Blvd., Hamadan, Iran.
Jerome R LechienDepartment of Otolaryngology-Head Neck Surgery, Elsan Hospital, Paris, France.
Aidin TarokhianHamadan University of Medical Sciences, Pajoohesh Blvd., Hamadan, Iran. tarokhianaidin@gmail.com.ORCID http://orcid.org/0000-0002-6168-5168

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe objective of this study was to train machine learning models for predicting the likelihood of recurrence in patients diagnosed with well-differentiated thyroid cancer. While thyroid cancer mortality remains low, the risk of recurrence is a significant concern. Identifying individual patient recurrence risk is crucial for guiding subsequent management and follow-ups.

methodsIn this prospective study, a cohort of 383 patients was observed for a minimum duration of 10 years within a 15-year timeframe. Thirteen clinicopathologic features were assessed to predict recurrence potential. Classic (K-nearest neighbors, support vector machines (SVM), tree-based models) and artificial neural networks (ANN) were trained on three distinct combinations of features: a data set with all features excluding American Thyroid Association (ATA) risk score (12 features), another with ATA risk alone, and a third with all features combined (13 features). 283 patients were allocated for the training process, and 100 patients were reserved for the validation of stage.

resultsThe patients' mean age was 40.87 ± 15.13 years, with a majority being female (81%). When using the full data set for training, the models showed the following sensitivity, specificity and AUC, respectively: SVM (99.33%, 97.14%, 99.71), K-nearest neighbors (83%, 97.14%, 98.44), Decision Tree (87%, 100%, 99.35), Random Forest (99.66%, 94.28%, 99.38), ANN (96.6%, 95.71%, 99.64). Eliminating ATA risk data increased models specificity but decreased sensitivity. Conversely, training exclusively on ATA risk data had the opposite effect.

conclusionsMachine learning models, including classical and neural networks, efficiently stratify the risk of recurrence in patients with well-differentiated thyroid cancer. This can aid in tailoring treatment intensity and determining appropriate follow-up intervals.

Indexed as

Thyroid NeoplasmsAdultCohort StudiesHumansMachine LearningMiddle AgedProspective StudiesRetrospective StudiesRisk AssessmentRisk FactorsArtificial intelligenceMachine learningRecurrenceThyroid cancer

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.